Why is Boston Bio falling/rising?

As of 10-Oct, Boston Bio Systems Ltd's stock price is currently at 8.19, reflecting a decline of 0.43, or 4.99%. The stock has been underperforming, having fallen consecutively for the last two days, resulting in a total drop of 9.7% during this period. Additionally, the stock's performance today has lagged behind its sector by 4.55%. In terms of returns, the stock has decreased by 7.67% over the past week and 1.80% over the past month, while there is no year-to-date or yearly return data available. Notably, investor participation has also diminished, with delivery volume dropping by 70.28% compared to the five-day average, indicating a lack of interest among investors.
Broader Market Context: In contrast, the benchmark Sensex has shown positive movement, gaining 1.59% over the past week and 1.32% over the past month. This stark difference highlights the stock's underperformance relative to the broader market. While the stock is trading above its 50-day and 100-day moving averages, it is below its 5-day, 20-day, and 200-day moving averages, suggesting a bearish trend. Overall, the combination of declining stock performance, reduced investor participation, and the contrasting positive performance of the benchmark indicates that Boston Bio Systems Ltd is currently facing significant challenges in the market.